Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Health
Henry Saker-Clark

Wegovy obesity drug sales more than double but set to slow

Novo Nordisk reported soaring sales for weight loss drug Wegovy (James Manning/PA) - (PA Wire)

Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted growth will slow this year.

The Danish pharmaceutical company has become one of Europe’s largest companies on the back of soaring demand for its obesity treatments.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.